Cargando…
The Robustness of Pathway Analysis in Identifying Potential Drug Targets in Non-Small Cell Lung Carcinoma
The identification of genes responsible for causing cancers from gene expression data has had varied success. Often the genes identified depend on the methods used for detecting expression patterns, or on the ways that the data had been normalized and filtered. The use of gene set enrichment analysi...
Autores principales: | Dalby, Andrew, Bailey, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979055/ https://www.ncbi.nlm.nih.gov/pubmed/27600345 http://dx.doi.org/10.3390/microarrays3040212 |
Ejemplares similares
-
Analysis of Gene Expression Data from Non-Small Cell Lung Carcinoma Cell Lines Reveals Distinct Sub-Classes from Those Identified at the Phenotype Level
por: Dalby, Andrew R., et al.
Publicado: (2012) -
Therapeutic Targeting
of Regulated Signaling Pathways
of Non-Small Cell Lung Carcinoma
por: Hasan, Gulam Mustafa, et al.
Publicado: (2023) -
Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
por: Sosa Iglesias, Venus, et al.
Publicado: (2018) -
Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer
por: Gorachinov, Filip, et al.
Publicado: (2023) -
Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma
por: Wangari-Talbot, Janet, et al.
Publicado: (2013)